# OnCo record nct04893109 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04893109/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04893109", "NCT04893109" ;
  schema:name "ATEMPT 2.0"@en ;
  schema:alternateName "ATEMPT 2.0: Adjuvant T-DM1 vs TH"@en ;
  schema:description "ATEMPT 2.0 compares a shorter course of T-DM1 followed by trastuzumab with paclitaxel and trastuzumab after breast surgery, tracking side effects and cancer recurrence."@en ;
  schema:url <https://onco.cc/trials/nct04893109/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04893109>, <https://clinicaltrials.ucsf.edu/trial/NCT04893109> ;
  onco:status "recruiting" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "2" ;
  schema:startDate "2021-06-16" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-emtansine/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .
